GU5 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Watchlist Manager

Watchlist

Price: 1.47 EUR Market Closed

Market Cap: €4.5B

G	Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd F:GU5	CN
	Orbital Corporation Ltd ASX:OEC	AU

Profitability Summary

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's profitability score is 45/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

16%

Sustainable 3Y Average Gross Margin

17%

Declining Gross Margin

19% > 16%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

6% > 4%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

6% > 4%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

View All

Hide

Collapse

45 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

16%

Sustainable 3Y Average Gross Margin

17%

Declining Gross Margin

19% > 16%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

6% > 4%

Low Net Margin

Low 3Y Average Net Margin